Imricor Medical Systems Inc (ASX:IMR) chair and CEO Steve Wedan speaks to Proactive’s Andrew Scott at the virtual ASX Small and Mid-Cap Conference 2020.
Imricor Announces Sales Collaboration with Optoacoustics
12 August 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided cardiac ablation products, is pleased to announce a sales collaboration with Optoacoustics Ltd, the world leader in innovative, high performance optical communication solutions for magnetic resonance (MR) applications.
Imricor Announces First Sales Collaboration with Philips
4 August 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the worldwide leader in MRI-guided cardiac ablation products, is pleased to announce the first sales collaboration with Philips, a global leader in healthcare technology.
Amsterdam UMC Becomes First to Perform Cardiac Catheter Ablation in Diagnostic MRI Lab
23 June 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) is pleased to announce the first procedure using the Company’s products in a traditional diagnostic MRI lab have been performed at the Amsterdam University Medical Center.
Haga Hospital Becomes First in the Benelux To Perform Cardiac Catheter Ablation in the iCMR
5 June 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) is pleased to announce, the first two successful cardiac catheter ablation procedures using the Company’s product at the Haga Hospital. These procedures are a first for heart care in the Benelux.
Imricor Announces First Cases Successfully Performed At Heart Center Dresden
Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) is pleased to announce the first procedures using the Company’s products following CE mark of the Vision-MR Ablation Catheter have been performed at the Heart Center Dresden.
Vision-MR Ablation Catheter Receives CE Mark
Imricor Medical Systems, Inc. (ASX:IMR) today announces that it has received CE mark approval for its Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode. This follows earlier CE mark approval for Imricor to place its Advantage-MR EP Recorder/Stimulator System on the market in the European Union. Imricor is the first and only company to offer cardiac ablation in the MRI environment.
Nick Twohy Joins Imricor Executive Team
Imricor Medical Systems, Inc. (ASX:IMR), a leading developer of innovative MRI-compatible medical devices, announced today Nick Twohy has joined the company’s executive team as the Director of Marketing.
Haga Hospital in the Netherlands to Install State-of-the-Art MRI Ablation Center
Imricor announced today that they have signed a commercial agreement with the Haga Hospital in The Hague, Netherlands to outfit an MRI ablation center for treating cardiac arrhythmias.
Amsterdam University Medical Center to be first Dutch hospital to adopt real-time MRI-guided cardiac ablations
Imricor announced today that it signed its first commercialization contract in the Netherlands with the Amsterdam University Medical Center, location VUmc, for the Advantage-MR™ EP Recorder/Stimulator System. With this agreement, Amsterdam UMC will become the first Dutch site to install the Advantage-MR system and perform real-time MRI-guided cardiac ablations, placing them at the forefront of clinical adoption for interventional cardiac magnetic resonance (iCMR) electrophysiology procedures.